(Q42990062)

12 November 2017

1 reference

title

Perspectives for a hepatitis C virus vaccine (English)

1 reference

12 November 2017

1 reference

1

1 reference

12 November 2017

Rosa D

2

1 reference

12 November 2017

publication date

1 July 1998

1 reference

Clinical and diagnostic virology

12 November 2017

published in

1 reference

12 November 2017

volume

10

1 reference

12 November 2017

issue

2-3

1 reference

12 November 2017

page(s)

181-185

1 reference

Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900028-2

7 January 2021

Therapy of hepatitis C: re-treatment with alpha interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900028-2

7 January 2021

T-lymphocyte response to hepatitis C virus in different clinical courses of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900028-2

7 January 2021

Vaccination of chimpanzees against infection by the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900028-2

7 January 2021

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900028-2

7 January 2021

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900028-2

7 January 2021

Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900028-2

7 January 2021

Effect of immune globulin on the prevention of experimental hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900028-2

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900028-2

7 January 2021

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900028-2

7 January 2021

A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900028-2

7 January 2021

Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900028-2

7 January 2021

Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900028-2

7 January 2021

10.1016/S0928-0197(98)00028-2

Identifiers

DOI

1 reference

12 November 2017

1 reference